Polymorphisms of human cytochrome P450 2C9 and the functional relevance
- 5 December 2010
- journal article
- review article
- Published by Elsevier BV in Toxicology
- Vol. 278 (2), 165-188
- https://doi.org/10.1016/j.tox.2009.08.013
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapyBlood Cells, Molecules, and Diseases, 2009
- Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomesLife Sciences, 2007
- Vitamin K epoxide reductase: homology, active site and catalytic mechanismTrends in Biochemical Sciences, 2004
- Stereoselective metabolism of methadone N‐demethylation by cytochrome P4502B6 and 2C19Chirality, 2003
- Preclinical Pharmacokinetics and Metabolism of BMS‐214778, a Novel Melatonin Receptor AgonistJournal of Pharmaceutical Sciences, 2003
- Measurement of 4-hydroxylation of ifosfamide in human liver microsomes using the estimation of free and protein-bound acrolein and codetermination of keto- and carboxyifosfamideZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish PopulationBiochemical and Biophysical Research Communications, 1999
- Biotransformation of Mestranol to Ethinyl Estradiol In Vitro: The Role of Cytochrome P‐450 2C9 and Metabolic InhibitorsThe Journal of Clinical Pharmacology, 1997
- Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liverLife Sciences, 1993
- Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9Biochemical and Biophysical Research Communications, 1991